BAXTER INTERNATIONAL INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
BAXTER INTERNATIONAL INC. (BAX) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $135.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-07-30
- BAXTER INTERNATIONAL INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $135.00M, a 10.66% increase year-over-year.
- BAXTER INTERNATIONAL INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$17.00M, a 126.56% decline year-over-year.
- BAXTER INTERNATIONAL INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$1.03B.
- BAXTER INTERNATIONAL INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$51.00M, a 183.61% decline year-over-year.
- BAXTER INTERNATIONAL INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was -$900.00M.
- BAXTER INTERNATIONAL INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$326.00M, a 280.11% decline from fiscal 2023.
- BAXTER INTERNATIONAL INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was $181.00M.
- BAXTER INTERNATIONAL INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$3.11B, a 401.36% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $135.00M 10-Q · filed 2026-07-30 | $118.00M 10-Q · filed 2026-07-30 | -$917.00M derived: sum of 3 quarters · filed 2026-07-30 | -$968.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$17.00M 10-Q · filed 2026-04-30 | -$1.05B derived: sum of 2 quarters · filed 2026-04-30 | -$1.10B derived: sum of 3 quarters · filed 2026-04-30 | -$981.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$1.03B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$1.09B derived: sum of 2 quarters · filed 2026-02-12 | -$964.00M derived: sum of 3 quarters · filed 2026-07-30 | -$900.00M 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | -$51.00M 10-Q · filed 2025-11-04 | $71.00M derived: sum of 2 quarters · filed 2026-07-30 | $135.00M 10-Q · filed 2025-11-04 | -$353.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $122.00M 10-Q · filed 2026-07-30 | $186.00M 10-Q · filed 2026-07-30 | -$302.00M derived: sum of 3 quarters · filed 2026-07-30 | -$241.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $64.00M 10-Q · filed 2026-04-30 | -$424.00M derived: sum of 2 quarters · filed 2026-04-30 | -$363.00M derived: sum of 3 quarters · filed 2026-04-30 | -$268.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | -$488.00M 10-K · filed 2025-02-21 | -$427.00M derived: sum of 2 quarters · filed 2025-11-04 | -$332.00M derived: sum of 3 quarters · filed 2025-11-04 | -$326.00M 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | $61.00M 10-Q · filed 2025-11-04 | $156.00M derived: sum of 2 quarters · filed 2025-11-04 | $162.00M 10-Q · filed 2025-11-04 | $381.00M derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2024-06-30 | $95.00M 10-Q · filed 2025-08-05 | -$311.00M 10-Q · filed 2024-08-06 | $101.00M 10-Q · filed 2025-08-05 | -$272.00M 10-Q · filed 2024-08-06 | $320.00M derived: sum of 3 quarters · filed 2025-08-05 | $357.00M derived: sum of 4 quarters · filed 2025-08-05 | ||
| 2024-03-31 | $6.00M 10-Q · filed 2025-05-06 | $39.00M 10-Q · filed 2024-05-02 | $225.00M derived: sum of 2 quarters · filed 2025-05-06 | $262.00M derived: sum of 3 quarters · filed 2025-05-06 | $235.00M derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | $219.00M 10-K · filed 2025-02-21 | $73.00M 10-K · filed 2024-02-08 | $256.00M derived: sum of 2 quarters · filed 2025-02-21 | $229.00M derived: sum of 3 quarters · filed 2025-02-21 | $181.00M 10-K · filed 2026-02-12 | -$69.00M 10-K · filed 2024-02-08 | ||
| 2023-09-30 | $37.00M 10-K · filed 2025-02-21 | $51.00M 10-Q · filed 2023-11-02 | $10.00M derived: sum of 2 quarters · filed 2025-02-21 | -$38.00M 10-Q · filed 2024-11-12 | -$142.00M 10-Q · filed 2023-11-02 | $106.00M derived: sum of 4 quarters · filed 2025-02-21 | ||
| 2023-06-30 | -$27.00M 10-K · filed 2025-02-21 | -$193.00M 10-Q · filed 2023-07-27 | -$193.00M 10-Q · filed 2024-08-06 | $69.00M derived: sum of 3 quarters · filed 2025-02-21 | -$2.92B derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2023-03-31 | -$48.00M 10-K · filed 2025-02-21 | $0.00 10-K · filed 2024-02-08 | $96.00M derived: sum of 2 quarters · filed 2025-02-21 | -$2.90B derived: sum of 3 quarters · filed 2025-02-21 | -$2.71B derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2022-12-31 | $144.00M 10-K · filed 2024-02-08 | -$2.85B derived: sum of 2 quarters · filed 2024-02-08 | -$2.66B derived: sum of 3 quarters · filed 2024-02-08 | -$3.11B 10-K · filed 2025-02-21 | -$2.65B 10-K · filed 2024-02-08 | |||
| 2022-09-30 | -$2.99B 10-K · filed 2024-02-08 | -$2.81B derived: sum of 2 quarters · filed 2024-02-08 | -$2.80B 10-Q · filed 2023-11-02 | |||||
| 2022-06-30 | $185.00M 10-K · filed 2024-02-08 | $193.00M 10-Q · filed 2023-07-27 | ||||||
| 2022-03-31 | $8.00M 10-K · filed 2024-02-08 | |||||||
| 2021-12-31 | $1.03B 10-K · filed 2024-02-08 | |||||||
| 2020-12-31 | $1.11B 8-K · filed 2021-04-29 | |||||||
| 2019-12-31 | $1.01B 8-K · filed 2021-04-29 | |||||||
| 2019-06-30 | $313.00M 10-K · filed 2020-03-17 | $655.00M 10-K · filed 2020-03-17 | $966.00M derived: sum of 3 quarters · filed 2020-03-17 | |||||
| 2019-03-31 | $342.00M 10-K · filed 2020-03-17 | $653.00M derived: sum of 2 quarters · filed 2020-03-17 | ||||||
| 2018-12-31 | $311.00M 10-K · filed 2020-03-17 | $1.55B 8-K · filed 2021-04-29 | ||||||
| 2018-06-30 | $341.00M 10-K · filed 2020-03-17 | $723.00M 10-K · filed 2020-03-17 | ||||||
| 2018-03-31 | $382.00M 10-K · filed 2020-03-17 | |||||||
| 2017-12-31 | $609.00M 10-K · filed 2020-03-17 | |||||||
| 2014-09-30 | $447.00M 10-Q · filed 2014-10-29 | $1.42B 10-Q · filed 2014-10-29 | ||||||
| 2013-09-30 | $528.00M 10-Q · filed 2014-10-29 | $1.60B 10-Q · filed 2014-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |